Contemporary Oncology (Feb 2024)

High-dose alectinib for RET fusion-positive non-small cell lung cancer in the Blood First Assay Screening Trial

  • Rafal Dziadziuszko,
  • Nir Peled,
  • Tony Mok,
  • Solange Peters,
  • Santiago Ponce Aix,
  • Jorge Alatorre-Alexander,
  • Brian D. Vicuna,
  • Margaret Maclennan,
  • Vijay Bhagawati-Prasad,
  • Sarah M. Shagan,
  • Erica Schleifman,
  • Thorsten Ruf,
  • Michael S. Mathisen,
  • Shirish M. Gadgeel

DOI
https://doi.org/10.5114/wo.2023.135246
Journal volume & issue
Vol. 27, no. 4
pp. 217 – 223

Abstract

Read online

No abstracts available.

Keywords